Special goat milk could protect cancer patients after transplant
NCT ID NCT04177004
Summary
This early-stage study is testing whether drinking milk from genetically engineered goats can help prevent a dangerous complication called graft-versus-host disease (GVHD) in blood cancer patients receiving a donor stem cell transplant. The milk contains a human enzyme called lysozyme, which may help promote healthy gut bacteria and reduce harmful infections. Researchers will compare patients who drink the special milk with those who receive standard care to see if it's safe and if it reduces transplant complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.